VivoSeq
Other

Coma

0

Pipeline Programs↗

3

Active Trials↗

1

Companies Involved↗

Coma is an early-stage landscape with 0 programs across 1 company. The most active players are UCB.

Intelligence

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

UCB logo

UCB

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

5

clinical trials

Completed2 · 40%
Recruiting2 · 40%
Active, not recruiting1 · 20%

Clinical Trials

Trial Activity

The COMACS Study: A Comparison of Methylphenidates in an Analog Classroom Setting
Completed·UCB logoUCB·Phase 4·NCT00381758·184 enrolled
Effect of Eurycoma Longifolia (DLBS5055) and Multivitamins (Vitamin C+Vitamin E+ Β-carotene) for Infertile Males
Active, not recruiting·—·Phase 4·NCT06100432·90 enrolled
Cangrelor in Comatose Survivors of OHCA Undergoing Primary PCI
Completed·UUniversity Medical Centre Ljubljana·Phase 4·NCT04005729·30 enrolled
Treatment of ELectrographic STatus Epilepticus After Cardiopulmonary Resuscitation-2: Multicenter Randomised Clinical Trial and Health Economic Evaluation of Anti-seizure Treatment in Comatose Cardiac Arrest Patients With SE on Continuous EEG
Recruiting·UUniversity of Twente·Preclinical·NCT06549426·150 enrolled
Use of Brain Structural and Functional Connectomes for the Prediction of Neurological Recovery in Coma Patients After Cardiac Arrest
Recruiting·UUniversity Hospital, Toulouse·Preclinical·NCT06617377·263 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)